T, F., MB, A., R, M., EM, N., & C, B. (2025). Dolutegravir use is related to lower HTLV-1 proviral load in people co-infected by HIV-1. Communications medicine, 6(1), 54. https://doi.org/10.1038/s43856-025-01312-9
Chicago Style (17th ed.) CitationT, Fernandez, Arriaga MB, Mayoral R, Netto EM, and Brites C. "Dolutegravir Use Is Related to Lower HTLV-1 Proviral Load in People Co-infected by HIV-1." Communications Medicine 6, no. 1 (2025): 54. https://doi.org/10.1038/s43856-025-01312-9.
MLA (9th ed.) CitationT, Fernandez, et al. "Dolutegravir Use Is Related to Lower HTLV-1 Proviral Load in People Co-infected by HIV-1." Communications Medicine, vol. 6, no. 1, 2025, p. 54, https://doi.org/10.1038/s43856-025-01312-9.
Warning: These citations may not always be 100% accurate.